Home > Healthcare > Medical Devices > Diagnostic Devices > Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Market Trends

Report ID: GMI6109
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Continuous Glucose Monitoring Market Trends

The growing burden of diabetes as a consequence of obesity across the world is one of the primary factors propelling the industry development. For instance, as per statistics, an obese person is six times more likely to develop diabetes mellitus as compared to a healthy person. Moreover, accompanying factors contributing to obesity include an inactive lifestyle, unhealthy eating habits, high consumption of alcohol and tobacco, poor gut health, high stress, and family history. These factors combined altogether result in diabetes in an individual. Moreover, technological advancements in manufacturing of digital diabetes devices for management of diabetes will further augment industry expansion.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market size for continuous glucose monitoring was USD 6.8 billion in 2023 and is projected to reach USD 20.2 billion by 2032, driven by the increasing number of type 1 and type 2 diabetes patients globally.

The sensors component segment generated USD 2.8 billion in 2022 and is poised to record substantial growth through 2032 owing to the rising need for early detection of hypoglycemia

U.S. industry amassed USD 2 billion in 2022 and is projected to grow at a notable CAGR through 2032 owing to the ongoing technological developments, rising healthcare spending, and the presence of well-established market participants in the country.

Some of the prominent companies in the continuous glucose monitoring market are Lifescan, Inc., Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.), Universal Biosensors, Taidoc Technology Corporation, Med Trust, Roche AG., Dexcom, Abbott, i-SENS, Inc., Trividia Health, and Medtronic,